How Freshdesk and Freshservice Work Together to Improve Support and IT Services 
ER2 Improves Ecommerce Fulfillment Nationwide with Descartes Solution Alterity Therapeutics Granted New Composition of Matter Patent in Europe for Neurodegenerative Diseases including Parkinson’s and Alzheimer’s
New Patent Covers Over 150 Novel Compounds MELBOURNE, Australia and SAN FRANCISCO, Aug. 23, 2023…
Sapu BioScience and Cromos Pharma initiating P201 – A Registrational trial for OT-101 in Pancreatic Cancer
AGOURA HILLS, Calif., Aug. 23, 2023 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc (OTCQB:OTLC) (“Oncotelic”, the…
Tiziana Life Sciences Announces Foralumab Presentation by Dr. Howard Weiner at the Annual Meeting of the International Society of Neuroimmunology
NEW YORK, Aug. 23, 2023 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or…
Sapu BioScience and Cromos Pharma initiating P201 – A Registrational trial for OT-101 in Pancreatic Cancer
AGOURA HILLS, Calif., Aug. 23, 2023 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc (OTCQB:OTLC) (“Oncotelic”, the…
TFF Pharmaceuticals to Participate in the H.C. Wainwright 25th Annual Global Investment Conference – September 11-13, 2023
FORT WORTH, Texas, Aug. 23, 2023 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage…
ANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of Directors
— Mr. Leonard is an accomplished leader with 35 years of pharmaceuticals and healthcare experience…
UiPath Automation Cloud™ Achieves HITRUST Risk-based, 2-year Certification Demonstrating the Highest Level of Information Protection Assurance
HITRUST Risk-based, 2-year (r2) Certification validates UiPath is committed to strong cybersecurity and meeting key…
Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
DEER PARK, Ill., Aug. 23, 2023 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), an…
Pharvaris To Present at the 2023 HAEi Regional Conference EMEA
ZUG, Switzerland, Aug. 23, 2023 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company developing…
Al Jazeera Extends Relationship with Avid to Enable Subscription and SaaS Cloud-Based Production for Thousands of Users Around the World
Global broadcaster signs multi-year agreement to upgrade to Avid’s global tech platform and subscription tools…
CommerceIQ Cracks the Code of Incrementality in Retail Media
New Incrementality Estimation Module standardizes media ROI across retailers through iROAS metric and optimizes for…
Boson Motors Selects Cerence to Bring Human-Like Interaction to its Electric Trucks
Key design win marks Cerence’s progress in bringing immersive experiences to new areas of transportation,…
FourKites Announces Competitive Replacement Program for Enhanced Supply Chain Visibility
New program helps companies using other supply chain visibility solutions to easily transition to FourKites’…
Sphere 3D Corp. to Participate in H.C. Wainwright’s 25th Annual Global Investment Conference
Toronto, Ontario–(Newsfile Corp. – August 23, 2023) – Sphere 3D Corp. (NASDAQ: ANY) (“Sphere 3D”…
RPP Containers is the Exclusive Stocking Distributor of ALPAL Stackable Foldable IBC in the United States
CINCINNATI–(BUSINESS WIRE)–RPP Containers, a leading manufacturer and stocking distributor of reusable bulk containers, has partnered…
Concentric AI Announces Multi-Lingual Support to Address Growing Global Demand for its Leading Data Security Posture Management Solution
Large Language Models which Power Concentric AI’s DSPM Solution Now Support Security Needs for Data…
Otus Unveils AI-Powered Assessment Features
CHICAGO–(BUSINESS WIRE)–#Edtech–Otus, a leader in K-12 student data technology, today announced the launch of its…
AIM ImmunoTech Rejects Director Nomination Notice from Activist Group Due to Numerous Material Defects, Omissions and False and Misleading Statements
Group Seeking to Take Control of 75% of AIM Board Failed to Properly Disclose Myriad…
Bionomics Completes Last Patient Last Visit in the Phase 2b ATTUNE Study for Post-Traumatic Stress Disorder (PTSD) and Confirms Expected 2023 Milestones with its Lead Asset BNC210
The last patient last visit has been completed in the Phase 2b ATTUNE study of…
Bionomics Completes Last Patient Last Visit in the Phase 2b ATTUNE Study for Post-Traumatic Stress Disorder (PTSD) and Confirms Expected 2023 Milestones with its Lead Asset BNC210
The last patient last visit has been completed in the Phase 2b ATTUNE study of…